GlassScriptPhysician profile
Jasmine Robertson
NPI 1922756733
$10,861.34
in general payments reported to CMS, 2019-2025
27 companies · $4,051 in 2025
The $4,051 reported for 2025 was more than what 98% of Psychiatric/Mental Health (Nurse Practitioner) providers received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $1,577 · 2023: $2,668 · 2024: $2,565 · 2025: $4,051.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,277 · Education: $7.52.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,276.50 |
| Education | $7.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,450.30 | 2022-2025 | |
| Neurocrine Biosciences, INC. | $1,113.31 | 2022-2025 | Ingrezza |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $1,101.72 | 2022-2025 | Caplyta |
| Otsuka America Pharmaceutical, INC. | $1,063.35 | 2022-2025 | Rexulti, Nuedexta, Abilify Maintena |
| Vanda Pharmaceuticals INC. | $874.32 | 2022-2025 | Fanapt |
| Lundbeck LLC | $652.40 | 2022-2025 | Rexulti, Brintellix, Abilify Asimtufii |
| Corium, LLC | $617.25 | 2022-2025 | Azstarys |
| Validus Pharmaceuticals LLC | $610.17 | 2022-2025 | Equetro, Equetro, Raldesy |
| Teva Pharmaceuticals USA, INC. | $526.54 | 2022-2025 | Austedo Xr, Austedo Xr, Uzedy |
| Alkermes, INC. | $445.45 | 2023-2025 | Lybalvi, Aristada, Vivitrol |
| Axsome Therapeutics, INC. | $394.93 | 2022-2025 | Auvelity |
| E.R. Squibb & Sons, L.L.C. | $337.63 | 2024-2025 | Cobenfy |
| Supernus Pharmaceuticals, INC. | $244.14 | 2023-2025 | Qelbree, Qelbree |
| Janssen Pharmaceuticals, INC | $243.17 | 2022-2025 | Invega Sustenna, Spravato, Invega |
| Idorsia Pharmaceuticals US INC | $216.60 | 2022-2024 | Quviviq |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $155.81 | 2022-2025 | Trintellix |
| Tris Pharma INC | $130.10 | 2023-2025 | Dyanavel Xr |
| Ironshore Pharmaceuticals INC. | $119.27 | 2022 | |
| Noven Therapeutics, LLC | $119.21 | 2023-2024 | Secuado |
| Sunovion Pharmaceuticals INC. | $109.72 | 2022 | |
| Almatica Pharma LLC | $96.38 | 2022-2023 | Loreev Xr, Sertraline Hcl |
| Bausch Health US, LLC | $72.62 | 2022-2024 | Wellbutrin, Aplenzin |
| Collegium Pharmaceutical, INC. | $48.60 | 2025 | Jornay Pm |
| Vertical Pharmaceuticals, LLC | $47.10 | 2024-2025 | Relexxii |
| Harmony Biosciences LLC | $30.44 | 2022 | |
| Ethicon US, LLC | $24.96 | 2025 | Ethicon |
| Alfasigma USA, INC. | $15.85 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jasmine Robertson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.